Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-amido-C3-COOH is a synthesized conjugate of an E3 ligase ligand-linker compound that combines a cereblon ligand derived from Thalidomide with a linker commonly employed in PROTAC technology.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 61.00 | |
5 mg | Inquiry | $ 98.00 |
Description | Thalidomide-O-amido-C3-COOH is a synthesized conjugate of an E3 ligase ligand-linker compound that combines a cereblon ligand derived from Thalidomide with a linker commonly employed in PROTAC technology. |
Synonyms | Cereblon Ligand-Linker Conjugates 7, E3 ligase Ligand-Linker Conjugates 15 |
Molecular Weight | 417.37 |
Formula | C19H19N3O8 |
CAS No. | 2308035-51-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55.5 mg/mL (132.98 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-amido-C3-COOH 2308035-51-8 Others Cereblon Ligand-Linker Conjugates 7 ThalidomideOamidoC3COOH Thalidomide-O-amido-C-3-COOH E3 ligase Ligand-Linker Conjugates 15 Thalidomide O amido C3 COOH inhibitor inhibit